vs
Side-by-side financial comparison of Armour Residential REIT, Inc. (ARR) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $50.4M, roughly 1.5× Armour Residential REIT, Inc.). Armour Residential REIT, Inc. runs the higher net margin — 420.2% vs 7.4%, a 412.8% gap on every dollar of revenue. On growth, Armour Residential REIT, Inc. posted the faster year-over-year revenue change (297.9% vs 25.5%). Over the past eight quarters, Armour Residential REIT, Inc.'s revenue compounded faster (108.0% CAGR vs 22.7%).
Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
ARR vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $50.4M | $76.2M |
| Net Profit | $211.7M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | — | 11.0% |
| Net Margin | 420.2% | 7.4% |
| Revenue YoY | 297.9% | 25.5% |
| Net Profit YoY | 555.9% | 30.7% |
| EPS (diluted) | $2.43 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.4M | $76.2M | ||
| Q3 25 | $38.5M | $71.9M | ||
| Q2 25 | $33.1M | $63.1M | ||
| Q1 25 | $36.3M | $59.1M | ||
| Q4 24 | $12.7M | $60.7M | ||
| Q3 24 | — | $58.0M | ||
| Q2 24 | $7.0M | $55.0M | ||
| Q1 24 | — | $50.6M |
| Q4 25 | $211.7M | $5.6M | ||
| Q3 25 | $159.3M | $3.5M | ||
| Q2 25 | $-75.6M | $3.2M | ||
| Q1 25 | $27.3M | $2.6M | ||
| Q4 24 | $-46.4M | $4.3M | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | $-48.4M | $1.5M | ||
| Q1 24 | — | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | — | 11.0% | ||
| Q3 25 | — | 7.8% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 4.4% |
| Q4 25 | 420.2% | 7.4% | ||
| Q3 25 | 413.5% | 4.9% | ||
| Q2 25 | -228.4% | 5.0% | ||
| Q1 25 | 75.2% | 4.4% | ||
| Q4 24 | -366.8% | 7.1% | ||
| Q3 24 | — | 6.7% | ||
| Q2 24 | -693.8% | 2.7% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | $2.43 | $0.14 | ||
| Q3 25 | $1.49 | $0.09 | ||
| Q2 25 | $-0.94 | $0.08 | ||
| Q1 25 | $0.32 | $0.06 | ||
| Q4 24 | $-0.91 | $0.10 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | $-1.05 | $0.04 | ||
| Q1 24 | — | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.3M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.3B | $141.5M |
| Total Assets | $21.0B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.3M | $13.5M | ||
| Q3 25 | $44.2M | $11.1M | ||
| Q2 25 | $141.2M | $20.0M | ||
| Q1 25 | $49.1M | $10.2M | ||
| Q4 24 | $68.0M | $17.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | $126.6M | $8.8M | ||
| Q1 24 | — | $7.3M |
| Q4 25 | $2.3B | $141.5M | ||
| Q3 25 | $2.1B | $133.6M | ||
| Q2 25 | $1.7B | $139.7M | ||
| Q1 25 | $1.7B | $134.8M | ||
| Q4 24 | $1.4B | $131.4M | ||
| Q3 24 | — | $125.0M | ||
| Q2 24 | $1.2B | $119.4M | ||
| Q1 24 | — | $116.3M |
| Q4 25 | $21.0B | $199.2M | ||
| Q3 25 | $19.4B | $202.4M | ||
| Q2 25 | $16.2B | $184.6M | ||
| Q1 25 | $15.5B | $178.1M | ||
| Q4 24 | $13.5B | $177.1M | ||
| Q3 24 | — | $169.5M | ||
| Q2 24 | $10.1B | $163.9M | ||
| Q1 24 | — | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $124.2M | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | 0.59× | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $124.2M | $18.4M | ||
| Q3 25 | $-37.8M | $18.4M | ||
| Q2 25 | $25.0M | $12.3M | ||
| Q1 25 | $101.5M | $2.9M | ||
| Q4 24 | $261.5M | $15.0M | ||
| Q3 24 | — | $12.7M | ||
| Q2 24 | $27.1M | $10.2M | ||
| Q1 24 | — | $1.2M |
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $10.7M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $-12.6M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-4.8M |
| Q4 25 | — | 12.7% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | — | -21.4% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -9.5% |
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 26.2% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | — | 19.0% | ||
| Q2 24 | — | 16.3% | ||
| Q1 24 | — | 11.9% |
| Q4 25 | 0.59× | 3.27× | ||
| Q3 25 | -0.24× | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | 3.71× | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | — | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
